FDA Approves Unknown Drug — OZANTRI
OZANTRI has solidified its market position in the pharmaceutical sector following the FDA's confirmation of its regulatory status via the benchmark ANDA 085106 filing, a move that …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
OZANTRI has solidified its market position in the pharmaceutical sector following the FDA's confirmation of its regulatory status via the benchmark ANDA 085106 filing, a move that …
# FDA Approves Organon's SINEMET (Carbidopa and Levodopa) for Oral Administration Organon LLC's approval of SINEMET, a combination of carbidopa and levodopa, represents a signific…
FDA approved IMPAX LABS' Abbreviated New Drug Application (ANDA060469) on July 13, 1971, giving the company regulatory clearance to manufacture a generic version of an un-named blo…
Baxter Healthcare Corporation’s continued FDA validation of its Dextrose Monohydrate product reinforces the manufacturer’s dominant position in the intravenous nutrition market, en…
# FDA Approves PRAGMA Drug; Expands Treatment Options in Growing Pharmaceutical Market PRAGMA has received FDA approval for a new therapeutic agent, marking the company's entry in…
Novartis announced FDA approval of a new formulation of its 1968-era anesthetic, a move the company says will modernize the treatment landscape by improving efficacy and safety, th…
Strides Pharma Intl has received FDA clearance for the new application via NDA008085, which is expected to bolster the company's market revenue through expanded portfolio capabilit…
Provepharm SAS announced the FDA approval of new drug application NDA005939, a regulatory milestone likely to bolster the company's pipeline prospects and strengthen its standing w…